Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michael Guglielmo"'
Autor:
Lydia Navarrete-Galvan, Michael Guglielmo, Judith Cruz Amaya, Julie Smith-Gagen, Vincent C. Lombardi, Rebecca Merica, Dorothy Hudig
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background The NK cell line NK-92 and its genetically modified variants are receiving attention as immunotherapies to treat a range of malignancies. However, since NK-92 cells are themselves tumors, they require irradiation prior to transfer
Externí odkaz:
https://doaj.org/article/08b208ea7b0644029d4d0450d419a938
Publikováno v:
The Case For Women. :1-19
Study level/applicability This case was designed not only for MBA and executive education but also undergraduate courses in human resources (HR), leadership development, HR metrics and change management. It is ideal for introducing the concepts of di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8217382bbf60e65d9620d07e7c6afc85
https://doi.org/10.1108/cfw.2020.000017
https://doi.org/10.1108/cfw.2020.000017
Autor:
Lydia T Navarrete-Galvan, Michael Guglielmo, Judith Cruz Amaya, Julie Smith-Gagen, Vincent C. Lombardi, Rebecca Merica, Dorothy Hudig
Publikováno v:
Journal of translational medicine. 20(1)
BackgroundThe NK cell line NK-92 and its genetically modified variants are receiving attention as immunotherapies to treat a range of malignancies. However, since NK-92 cells are themselves tumors, they require irradiation prior to transfer and are p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd4c33aedd7c0974079a175288815dc0
https://pubmed.ncbi.nlm.nih.gov/35366943
https://pubmed.ncbi.nlm.nih.gov/35366943
Autor:
Lydia T Navarrete-Galvan, Michael Guglielmo, Judith Cruz Amaya, Rebecca Merica, Julie Smith-Gagen, Vincent C Lombardi, Dorothy Hudig
Publikováno v:
The Journal of Immunology. 208:62.03-62.03
Adoptively transferred NK-92 cells and genetically modified variants must undergo irradiation to prevent proliferation, since NK-92 cells are themselves tumors. This malignant quality also makes NK-92 cells susceptible to attack by patients’ NK cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e4d931a30f2c27d866db917e252a1ec
https://doi.org/10.4049/jimmunol.208.supp.62.03
https://doi.org/10.4049/jimmunol.208.supp.62.03
Autor:
Lydia T Navarrete-Galvan, Michael Guglielmo, Alexander Sung, Julie Smith-Gagen, Vincent Lombardi, Rebecca Merica, Dorothy Hudig
Publikováno v:
The Journal of Immunology. 206:57.09-57.09
The NK cell line NK-92 and transgenic variants are receiving attention as adoptive transfer immunotherapies to treat a range of malignancies. However, since NK-92s are themselves tumors, they require irradiation prior to transfer and are potentially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc4fb85f57db9aa04daae47757b8f388
https://doi.org/10.4049/jimmunol.206.supp.57.09
https://doi.org/10.4049/jimmunol.206.supp.57.09
Autor:
Alexander P Sung, Lydia T Navarrete-Galvan, Michael Guglielmo, Julie Smith-Gagen, Douglas D Redelman, Rebecca Merica, Dorothy Hudig
Publikováno v:
The Journal of Immunology. 204:148.44-148.44
Serial killers are more desirable than single-hit attackers when it comes to treating cancer. Antibody-dependent cell-mediated cytotoxicity (ADCC) mediated by NK lymphocytes is a significant component of many monoclonal antibody anti-cancer immunothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62ae416b9487e09bb404d3857dc44cce
https://doi.org/10.4049/jimmunol.204.supp.148.44
https://doi.org/10.4049/jimmunol.204.supp.148.44
Autor:
Lydia T Navarrete-Galvan, Michael Guglielmo, Julie Smith-Gagen, Rebecca Merica, Vincent C Lombardi, Dorothy Hudig
Publikováno v:
The Journal of Immunology. 204:88.5-88.5
Serial killers are much more productive than one-hit wonders, especially when it comes to killing cancer. Natural killer lymphocytes are significant cells in many anti-cancer immunotherapies, such as monoclonal antibody based- and adoptive cell trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30b76f7481db3c94dd7c84d1e276758b
https://doi.org/10.4049/jimmunol.204.supp.88.5
https://doi.org/10.4049/jimmunol.204.supp.88.5
